LADENBURG THALMANN FINANCIAL SERVICES INC. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 97 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,0000.0%1,2500.0%0.00%
Q3 2019$5,0000.0%1,250
-7.4%
0.00%
Q2 2019$5,000
-28.6%
1,3500.0%0.00%
Q1 2019$7,000
+600.0%
1,350
+440.0%
0.00%
Q4 2018$1,000
-87.5%
250
-70.6%
0.00%
Q3 2018$8,000
-27.3%
8500.0%0.00%
Q2 2018$11,0000.0%8500.0%0.00%
Q1 2018$11,0000.0%850
+41.7%
0.00%
Q4 2017$11,000
+10.0%
600
+50.0%
0.00%
Q3 2017$10,0004000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders